118 related articles for article (PubMed ID: 35102114)
1. Impact of psoas muscle index assessed by a simple measurement method on tolerability and duration of continued treatment with sorafenib in hepatocellular carcinoma patients.
Ogushi K; Chuma M; Numata K; Nozaki A; Moriya S; Uojima H; Kondo M; Morimoto M; Maeda S
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):774-781. PubMed ID: 35102114
[TBL] [Abstract][Full Text] [Related]
2. Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization.
Zhang JX; Yan HT; Ding Y; Liu J; Liu S; Zu QQ; Shi HB
Ann Med; 2022 Dec; 54(1):1562-1569. PubMed ID: 35639492
[TBL] [Abstract][Full Text] [Related]
3. Combination of psoas muscle mass index and neutrophil-to-lymphocyte ratio as a noninvasive prognostic marker in hepatocellular carcinoma patients undergoing radiofrequency ablation.
Hayashi M; Abe K; Fujita M; Takahashi A; Ohira H
Eur J Gastroenterol Hepatol; 2023 May; 35(5):568-574. PubMed ID: 37115983
[TBL] [Abstract][Full Text] [Related]
4. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
Ebadi M; Wang CW; Lai JC; Dasarathy S; Kappus MR; Dunn MA; Carey EJ; Montano-Loza AJ;
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1053-1062. PubMed ID: 30269421
[TBL] [Abstract][Full Text] [Related]
5. Association between Skeletal Muscle Depletion and Sorafenib Treatment in Male Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study.
Naganuma A; Hoshino T; Suzuki Y; Uehara D; Kudo T; Ishihara H; Sato K; Kakizaki S; Yamada M; Takagi H
Acta Med Okayama; 2017 Aug; 71(4):291-299. PubMed ID: 28824184
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Psoas Muscle Mass Index in Patients With Non‒ST-Segment‒Elevation Myocardial Infarction: A Prospective Observational Study.
Matsumoto H; Matsumura K; Yamamoto Y; Fujii K; Tsujimoto S; Otagaki M; Morishita S; Hashimoto K; Shibutani H; Sugiura T; Shiojima I
J Am Heart Assoc; 2020 Oct; 9(19):e017315. PubMed ID: 32975168
[TBL] [Abstract][Full Text] [Related]
7. A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma.
Noguchi G; Kawahara T; Kobayashi K; Tsutsumi S; Ohtake S; Osaka K; Umemoto S; Nakaigawa N; Uemura H; Kishida T; Yao M
PLoS One; 2020; 15(1):e0226581. PubMed ID: 31895931
[TBL] [Abstract][Full Text] [Related]
8. [Impact of psoas muscle index on early postoperative mortality and complications after liver transplantation].
Hou JC; Zheng H; Qiang Z; Zhang YM; Jiang WT; Gao W; Cai JZ; Zhang JJ; Shen ZY
Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):374-378. PubMed ID: 29779314
[No Abstract] [Full Text] [Related]
9. Low psoas muscle index is a poor prognostic factor for lower gastrointestinal perforation: a single-center retrospective cohort study.
Kayano H; Nomura E; Abe R; Ueda Y; Machida T; Fujita C; Uchiyama S; Endo K; Murakami K; Mukai M; Makuuchi H
BMC Surg; 2019 Nov; 19(1):181. PubMed ID: 31779610
[TBL] [Abstract][Full Text] [Related]
10. Psoas muscle index and psoas muscle density as predictors of mortality in patients undergoing hemodialysis.
Yajima T; Arao M; Yajima K
Sci Rep; 2022 Jun; 12(1):10496. PubMed ID: 35729286
[TBL] [Abstract][Full Text] [Related]
11. Impact of skeletal muscle mass on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Uchida Y; Ishii H; Tanaka A; Yonekawa J; Satake A; Makino Y; Suzuki W; Kurobe M; Mizutani K; Mizutani Y; Fujimoto M; Ichimiya H; Teramoto C; Tamenishi A; Okamoto H; Watanabe J; Kanashiro M; Amano T; Matsubara T; Ichimiya S; Murohara T
Cardiovasc Interv Ther; 2021 Oct; 36(4):514-522. PubMed ID: 33128695
[TBL] [Abstract][Full Text] [Related]
12. Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study.
Ueki H; Hara T; Okamura Y; Bando Y; Terakawa T; Furukawa J; Harada K; Nakano Y; Fujisawa M
Investig Clin Urol; 2022 Jul; 63(4):415-424. PubMed ID: 35796138
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors.
Luo N; Li H; Luo Y; Hu P; Liang L; Zhang R; Zhang D; Cai D; Kang J
Hum Vaccin Immunother; 2023 Aug; 19(2):2258567. PubMed ID: 37728115
[TBL] [Abstract][Full Text] [Related]
14. Measuring sarcopenia on pre-operative CT in older adults undergoing emergency laparotomy: a comparison of three different calculations.
Simpson G; Manu N; Magee C; Wilson J; Moug S; Vimalachandran D
Int J Colorectal Dis; 2020 Jun; 35(6):1095-1102. PubMed ID: 32215679
[TBL] [Abstract][Full Text] [Related]
15. Low muscle mass assessed by psoas muscle area is associated with clinical adverse events in elderly patients with heart failure.
Funamizu T; Nagatomo Y; Saji M; Iguchi N; Daida H; Yoshikawa T
PLoS One; 2021; 16(2):e0247140. PubMed ID: 33592068
[TBL] [Abstract][Full Text] [Related]
16. Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia.
Pigneur F; Di Palma M; Raynard B; Guibal A; Cohen F; Daidj N; Aziza R; El Hajjam M; Louis G; Goldwasser F; Deluche E
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1613-1620. PubMed ID: 37203274
[TBL] [Abstract][Full Text] [Related]
17. Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinoma.
Yukimoto A; Hirooka M; Hiraoka A; Michitaka K; Ochi H; Joko K; Imai Y; Watanabe T; Koizumi Y; Yoshida O; Abe M; Hiasa Y
Jpn J Clin Oncol; 2019 Jan; 49(1):42-47. PubMed ID: 30380075
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment.
Ogasawara S; Chiba T; Ooka Y; Suzuki E; Maeda T; Yokoyama M; Wakamatsu T; Inoue M; Saito T; Kobayashi K; Kiyono S; Nakamura M; Nakamoto S; Yasui S; Tawada A; Arai M; Kanda T; Maruyama H; Yokosuka O; Kato N
Invest New Drugs; 2018 Apr; 36(2):332-339. PubMed ID: 28891038
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
[TBL] [Abstract][Full Text] [Related]
20. Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan.
Ogasawara S; Ooka Y; Itokawa N; Inoue M; Okabe S; Seki A; Haga Y; Obu M; Atsukawa M; Itobayashi E; Mizumoto H; Sugiura N; Azemoto R; Kanayama K; Kanzaki H; Maruta S; Maeda T; Kusakabe Y; Yokoyama M; Kobayashi K; Kiyono S; Nakamura M; Saito T; Suzuki E; Nakamoto S; Yasui S; Tawada A; Chiba T; Arai M; Kanda T; Maruyama H; Kato N
Invest New Drugs; 2020 Feb; 38(1):172-180. PubMed ID: 31172442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
